The Brigham’s 7T MRI unit, just the second in the country to be approved for clinical use, revealed that a potential biomarker of brain inflammation in patients affected by multiple sclerosis is more common than previously thought.
The 16-hour surgery, involving a team of over 45 surgeons, nurses, anesthesiologists, residents and research fellows, and led by Bohdan Pomahac, MD, was the ninth face transplant procedure at the Brigham and the 15th nationwide.
A new study suggests positron emission tomography (PET) brain scans could reveal hidden inflammation in patients with multiple sclerosis (MS) who are being treated with highly-effective treatments. Read More...
MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests Read More...
Brigham and Women's Physician Organization, Inc. ("BWPO"), a member of Mass General Brigham Incorporated (MGB) is notifying individuals of an incident it recently became aware of involving some patients' personal information. Read More...
